Enhanced expressions of glucose-6-phosphate dehydrogenase and cytosolic aldehyde dehydrogenase and elevation of reduced glutathione level in cyclophosphamide-resistant human leukemia cells

Blood Cells, Molecules and Diseases

Volumn 24, Issue 2, 1998, Pages 231-238

  Tsukamoto, Norifumi ^a,b   Chen, James ^b   Yoshida, Akira ^b  

^a GUNMA UNIVERSITY   (Japan)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Aldehyde dehydrogenase; Drug resistance; Glucose 6 phosphate dehydrogenase; Glutathione; Leukemia cells

Indexed keywords

ALDEHYDE DEHYDROGENASE; CYCLOPHOSPHAMIDE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE;

ANIMAL CELL; ARTICLE; CANCER CHEMOTHERAPY; ENZYME ACTIVITY; LEUKEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032104727     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.1998.0188     Document Type: Article

References (27)

1. 1. Sladek NE. Metabolism of oxazaphosphorines. Pharmacol Ther 37:301-355, 1988.
2. 2. Radin AI, Zhoa X-L, Woo TH, Colvin M, Hilton J. Structure and expression of the cytosolic aldehyde dehydrogenase gene in cyclophosphamide-resistant murine leukemia L1210 cells. Biochem Pharm 42:1933-1939, 1993.
3. 3. Russo JE, Hilton J, Colvin OM. The role of aldehyde dehydrogenase isozymes in cellular resistance to the alkylating agent cyclophosphamide. Prog Clin Biol Res 290:65-79, 1989.
4. 4. Manthey CL, Sladek NE. Aldehyde dehydrogenase catalyzed bioinactivation of cyclophosphamide. Prog Clin Biol Res 290:49-63, 1989.
5. 5. Sreerama L, Sladek NE. Identification and characterization of a novel class 3 aldehyde dehydrogenase overexpressed in a human breast adenocarcinoma cell line exhibiting oxazaphos-phorine-specific acquired resistance. Biochem Pharm 45:2487-2505, 1993.
6. 6. Yoshida A, Rzhetsky A, Hsu LC, Chang C. Human aldehyde dehydrogenase gene family. Eur J Biochem 251:549-557, 1998.
7. 7. Arrick BA, Nathan CF. Glutathione metabolism as a determinant of therapeutic efficacy: a review. Cancer Res 44:4224-4232, 1984.
8. 8. Bailey HH, Gipp JJ, Ripple M, Wielding G, Mulcahy T. Increase in γ-glutamylcysteine synthetase activity and steady state messenger RNA levels in melphalan-resistant DU-145 human prostate carcinoma cells expressing elevated glutathione levels. Cancer Res 52:5115-5118, 1992.
9. 9. Bouffard DY, Momparler LF, Momparler RL. Comparison of antineoplastic activity of 2′,2′-difluorodeoxycytidine and cytosine arabinoside against human myeloid and lymphoid leukemic cells. Anti-Cancer Drugs 2:49-55, 1991.
10. 10. Lowry OH, Rosebrough NJ, Farr AL, Randall RL. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275, 1951.
11. 11. Kirkman HN, Hendrickson EM. Sex-linked electrophoretic difference in glucose-6-phosphate dehydrogenase. Am J Hum Genet 15:241-258, 1963.
12. 12. Ikawa M, Impraim CC, Wang G, Yoshida A. Isolation and characterization of aldehyde dehydrogenase isozymes from usual and atypical human livers. J Biol Chem 258:6282-6287, 1983.
13. 13. Beutler E, Gelbart T. Improved assay of the enzymes of glutathione synthesis: γ-glutamylcysteine synthetase and glutathione synthetase. Clin Chem Acta 158:115-123, 1986.
14. 14. Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 61:882-888, 1963.
15. 15. Sambrook J, Frinch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
16. 16. Thomas DS. Hybridization of denatured RNA and small DNA fragments transplanted to nitrocellulose. Proc Natl Acad Sci USA 77:5201-5205, 1980.
17. 17. Hsu LC, Chang W-C, Shibuya A, Yoshida A. Human stomach aldehyde dehydrogenase cDNA, genomic cloning, primary structure and expression in E.coli. J Biol Chem 267:3030-3037, 1992.
18. 18. Magni M, Shammah S, Schir[ ]R, Mellado W, Dalla-Favera R, Gianni AM. Induction of cyclophosphamide-resistance by aldehyde dehydrogenase gene transfer. Blood 87:1097-1103, 1996.
19. 19. Bunting KD, Townsend AI. De novo expression of transfected human class I aldehyde dehydrogenase (ALDH) causes resistance to oxazaphosphorine anti-cancer alkylating agents in hamster V79 cell lines. J Biol Chem 271:11884-11890, 1996.
20. 20. Bunting KD, Lindahl R, Townsend AJ. Oxazaphosphorine-specific resistance in human MCF-7 breast carcinoma cell lines expressing transfected rat class 3 aldehyde dehydrogenase. J Biol Chem 269:23197-23203, 1994.
21. 21. Bunting KD, Townsend AJ. Protection by transfected rat or human class 3 aldehyde dehydrogenase against the cytotoxic effect of oxazaphosphorine alkylating agents in hamster V79 cell lines. J Biol Chem 271: 11891-11896, 1996.
22. 22. Crook TR, Souhami RL, Whyman GD, McLean AEM. Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophos-phamide. Cancer Res 46:5035-5038, 1986.
23. 23. Goto S, Yoshida K, Morikawa T, Urata Y, Suzuki K, Kondo T. Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells. Cancer Res 55:4297-4301, 1995.
24. 24. Beutler E. The glutathione instability of drug-sensitive red cells. A new method for the in vitro detection of drug sensitivity. J Lab Clin Med 49:84-95, 1957.
25. 25. Yoshida A, DavJ V, Han H, Scanlon KJ. Enhanced transcription of the cytosolic ALDH gene in cyclophosphamide resistant human carcinoma cells. Adv Exp Med Biol 328:63-72, 1993.
26. 26. Frei III E, Teicher BA, Holden SA, Cathcart KNS, Wang Y. Preclinical studies and clinical correlation of the effect of alkylating dose. Cancer Res 48:6417-6423, 1988.
27. 27. Valerie RC, Pietruszko R. Human aldehyde dehydrogenase: mechanism of inhibition by disulfiram. Science 216:637-639, 1982.